MyFinsight
Home
Blog
About
Contact
Download
Download image
Marketable securities
$187,039K
Cash and cash
equivalents
$60,181K
Prepaid expenses and
other current assets
$13,719K
Total current assets
$260,939K
Property and equipment,
net
$34,771K
Other investments
$19,000K
Operating lease
right-of-useassets
$18,871K
Othernon-currentassets
$4,886K
Restricted cash
$1,585K
Total assets
$340,052K
Total liabilities and
stockholders equity
$340,052K
Total stockholders
equity
$248,202K
Total liabilities
$91,850K
Accumulated deficit
-$1,619,554K
Additionalpaid-incapital
$1,867,512K
Total current
liabilities
$49,412K
Operating lease
liabilities, non-current
$41,921K
Othernon-currentliabilities
$517K
Accumulated other
comprehensive income
$242K
Common stock, 0.0001
par value 500,000...
$2K
Accrued liabilities and
other current...
$46,519K
Accounts payable
$2,893K
Back
Back
Balance Sheet
source: myfinsight.com
Lyell Immunopharma, Inc. (LYEL)
Lyell Immunopharma, Inc. (LYEL)